Cancer Type,Sample Count,Model Used,MSE,TrainingTestandValidation,Full Training Time
Adrenocortical carcinoma (ACC),78,FLAML,694,NA,301.32s
Adrenocortical carcinoma (ACC),78,GCNConv,665.97,70%; 30%; 0%,186.29s
Breast invasive carcinoma (BRCA),1082,FLAML,1225,NA,303.59s
Breast invasive carcinoma (BRCA),1082,GCNConv,957.83,60%; 20% 20%,2644.00s
